Internetiühendust pole — kuvatakse lehe salvestatud versioon.

Amgen Inc

USUSD
← Aktsiafiltri Juurde
US:AMGNHK:4332LSE:0R0TMX:AMGNXETRA:AMG

Amgen Inc (XETRA:AMG) — Biotechnology: Biological Products (No Diagnostic Substances). Börside arv, kus ettevõtte aktsiatega kaubeldakse: 4. Sellel lehel — hind ja graafik, dividendid, suurimad aktsionärid ja aktsiate arvu ajalugu.

Ettevõtte Kohta

Veebileht
amgen.com
Investorite Suhted
investors.amgen.com/
Sektor
Health Care · Biotechnology: Biological Products (No Diagnostic Substances)
Peakontor
Thousand Oaks, United States
Tegevjuht
Robert A. Bradway
Töötajad
17 900
Asutatud
1980
Börsil Alates
17.11.1998 (XETRA:AMG)
Ringluses Olevad Aktsiad
540.63 mln seisuga 2026-07-30
Vabalt Kaubeldavad Aktsiad
539.16 mln
Turukapitalisatsioon
226.05 mld USD
Siseringi Isikud
0.23%
Institutsionaalsed Investorid
85.02%
Tegevusala (SIC)
Biological Products, (No Diagnostic Substances)
Õiguslik Vorm
XTIQ
ISIN
US0311621009
LEI
62QBXGPJ34PQ72Z12S66
Väljamaksesuhe
60.4%
FCF
10.2 mld USD
52%
Võlg
57.3 mld USD
4.3 a FCF
Dividendistaaž
15 a
Kasum, FCF ja dividendid makstud — 12 kuu jooksul kuni 30.06.2026 (ettevõtte viimane raport).
Kirjeldus

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company's principal products include Enbrel for the treatment of rheumatoid arthritis, plaque psoriasis, and psoriatic arthritis; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease; Prolia to treat postmenopausal women with osteoporosis; XGEVA for skeletal-related events prevention; Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization; Nplate for the treatment of patients with immune thrombocytopenia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; Aranesp to treat a lower-than-normal number of red blood cells and anemia; EVENITY for the treatment of osteoporosis in postmenopausal for women; Vectibix to treat patients with wild-type RAS metastatic colorectal cancer; BLINCYTO for the treatment of patients with acute lymphoblastic leukemia; TEPEZZA to treat thyroid eye disease; and KRYSTEXXA for the treatment of chronic refractory gout. It also markets other products, including PROLIA, REPATHA, OTEZLA, ENBREL, EVENITY, XGEVA, TEPEZZA, BLINCYTO, NPLATE, TEZSPIRE, KYPROLIS, ARANESP, KRYSTEXXA AND VECTIBIX, MVASI, PAVBLU, UPLIZNA, IMDELLTRA/IMDYLLTRA, AMJEVITA/AMGEVITA, TAVNEOS, NEULASTA, LUMAKRAS/LUMYKRAS, RAVICTI, PARSABIV, AIMOVIG, WEZLANA/WEZENLA, AND PROCYSBI. The company serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors. The company has collaboration agreements with AstraZeneca plc for the development and commercialization of TEZSPIRE; BEONE MEDICINES LTD. to develop and commercialize Aimovig; UCB for the development and commercialization of EVENITY; Kyowa Kirin Co., Ltd. for rocatinlimab development and commercialization; and BeiGene, Ltd. for oncology products expansion and development. The company was incorporated in 1980 and is headquartered in Thousand Oaks, California.

Börsid ja Tikkerid

BörsTikkerValuutaHindTüüp
US USA StocksAMGN põhinoteeringUSD414.87 +1.82%tavalised aktsiad
HK Hong Kong Stock Exchange4332 lisanoteeringHKD—
LSE London Stock Exchange0R0T IOBUSD411.854 +1.17%tavalised aktsiad
MX Mexican Stock ExchangeAMGN lisanoteeringMXN7 500.0098 +0.00%tavalised aktsiad
XETRA XetraAMG lisanoteeringEUR367.95 -1.39%tavalised aktsiad

Hind 3 Kuu Jooksul

3M1Y3Y5Y
tõususepäev langusepäev dividendi ex-kuupäev väljamakse kuupäevViige kursor / puudutage päeva — avamis-, sulgemis-, kõrgeim ja madalaim hind

Dividendid

Aastas US:AMGN: 9.94 USD (4 väljam.)

Amgen Inc (AMGN) maksab dividende kvartalis. Aastas (12 kuud kuni viimase teatatud maksega): 9.94 USD aktsia kohta (maksed: 4). See on umbes 2.40% praegusest aktsiahinnast. Makseajaloo põhjal oodatakse järgmist ex-dividendi kuupäeva umbes 20.11.2026. Katkematu dividendiajalugu: 15 aastat.

Ex-KuupäevVäljamakseSumma%TüüpTikker
2026-08-212026-09-112.5200 USD0.6/2.4 %kord kvartalisUS:AMGN
2026-05-152026-06-052.5200 USD0.6/2.4 %kord kvartalisUS:AMGN
2026-02-132026-03-062.5200 USD0.6/2.3 %kord kvartalisUS:AMGN
2025-11-212025-12-122.3800 USD0.6/2.3 %kord kvartalisUS:AMGN
2025-08-222025-09-122.3800 USD0.6/2.3 %kord kvartalisUS:AMGN
2025-05-162025-06-062.3800 USD0.6/2.2 %kord kvartalisUS:AMGN
2025-02-142025-03-072.3800 USD0.6/≈2.3 %kord kvartalisUS:AMGN
2024-11-182024-12-092.2500 USD0.5/≈2.2 %kord kvartalisUS:AMGN
2024-08-162024-09-062.2500 USD0.5/≈2.2 %kord kvartalisUS:AMGN
reklaam

Suurimad Omanikud

OmanikOsalusAktsiadAruande Kuupäev
Blackrock Inc.9.13%49.36 mln2026-06-30
Vanguard Capital Managem…6.52%35.25 mln2026-06-30
State Street Corporation5.65%30.56 mln2026-06-30
Capital World Investors5.38%29.08 mln2026-06-30
VANGUARD INDEX FUNDS-Van…3.17%17.13 mln2026-06-30
Invesco Ltd.3.02%16.32 mln2026-06-30
Geode Capital Management…2.9%15.7 mln2026-06-30
Charles Schwab Investmen…2.78%15.03 mln2026-06-30
Vanguard Portfolio Manag…2.75%14.85 mln2026-06-30
VANGUARD INDEX FUNDS-Van…2.59%13.99 mln2026-06-30
Morgan Stanley2.53%13.65 mln2026-06-30
Invesco QQQ Trust, Serie…2.15%11.61 mln2026-08-31
SCHWAB STRATEGIC TRUST-S…1.81%9.79 mln2026-05-31
Income Fund of America1.44%7.76 mln2026-06-30
iShares Trust-iShares Co…1.35%7.28 mln2026-07-31
Wells Fargo & Company1.34%7.24 mln2026-06-30
AMERICAN BALANCED FUND1.31%7.09 mln2026-06-30
Fidelity Concord Street…1.29%6.98 mln2026-07-31
SPDR S&P 500 ETF TRUST-S…1.22%6.6 mln2026-08-31
WASHINGTON MUTUAL INVEST…1.16%6.27 mln2026-06-30
BRADWAY ROBERT A (Chief…≈0.12%657 2992026-05-05
SANTOS ESTEBAN (Officer)≈0.02%84 2792026-05-05
GORDON MURDO (Officer)≈0.01%51 8372026-05-05
GRIFFITH PETER H. (Chief…≈0.01%50 7062026-05-05
REESE DAVID M. (Chief Te…≈0.01%42 8122026-05-05
GRAHAM JONATHAN P (Gener…≈0.01%40 2112026-05-05
BRADNER JAMES E. (Office…≈0.01%30 4622026-05-05
ECKERT ROBERT ANDREW (Di…≈0%26 2512026-05-19
JACKS TYLER (Director)≈0%18 2842026-05-19
KULLMAN ELLEN JAMISON (D…≈0%14 5362026-05-19